SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-013726
Filing Date
2023-04-26
Accepted
2023-04-26 18:40:49
Documents
1
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5016
  Complete submission text file 0001493152-23-013726.txt   6656
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Reporting) CIK: 0001689739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 23851242